171 related articles for article (PubMed ID: 32128431)
1. Organ preservation following radiation therapy and concurrent intra-arterial low dose cisplatin infusion for advanced T2 and T3 laryngeal cancer: Long-term clinical results from a pilot study.
Ono T; Tanaka N; Tanoue S; Miyata Y; Muraki K; Tsuji C; Ogo E; Aso T; Chitose SI; Shin B; Kakuma T; Etoh H; Hattori C; Abe T; Umeno H
Laryngoscope Investig Otolaryngol; 2020 Feb; 5(1):55-65. PubMed ID: 32128431
[TBL] [Abstract][Full Text] [Related]
2. Comparative Treatment Outcome in T3N0 Glottic Cancer With and Without Vocal Fold Fixation Receiving Radiation Therapy and Concurrent Low-Dose Intra-Arterial Cisplatin Infusion.
Ono T; Tanaka N; Chitose SI; Tanoue S; Kurita T; Sueyoshi S; Fukahori M; Miyata Y; Muraki K; Tsuji C; Ogo E; Hattori C; Sato K; Abe T; Umeno H
Ann Otol Rhinol Laryngol; 2022 Aug; 131(8):897-904. PubMed ID: 34565187
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy with an oral fluoropyrimidine, S-1, following reduced RADPLAT in advanced laryngeal cancer.
Wakisaka N; Kondo S; Endo K; Murono S; Yoshizaki T
Ann Otol Rhinol Laryngol; 2012 Aug; 121(8):555-62. PubMed ID: 22953663
[TBL] [Abstract][Full Text] [Related]
4. Functional organ preservation in locally advanced laryngeal squamous cell carcinoma: is there a role for induction chemotherapy?
Loo SW; Geropantas K; Roques TW
Clin Oncol (R Coll Radiol); 2013 May; 25(5):298-307. PubMed ID: 23290343
[TBL] [Abstract][Full Text] [Related]
5. Intra-arterial cisplatin with concomitant radiation for advanced hypopharyngeal cancer.
Nomura K; Takahara M; Katayama A; Kishibe K; Kunibe I; Katada A; Hayashi T; Harabuchi Y
Laryngoscope; 2013 Apr; 123(4):916-22. PubMed ID: 23280966
[TBL] [Abstract][Full Text] [Related]
6. Treatment outcomes of locally advanced squamous cell carcinoma of the maxillary sinus treated with chemoradioselection using superselective intra-arterial cisplatin and concomitant radiation: Implications for prognostic factors.
Ono T; Tanaka N; Umeno H; Chitose SI; Shin B; Aso T; On K; Hattori C; Etoh H; Kakuma T; Abe T
J Craniomaxillofac Surg; 2017 Dec; 45(12):2128-2134. PubMed ID: 29122485
[TBL] [Abstract][Full Text] [Related]
7. Superselective intra-arterial chemoradiation therapy for functional laryngeal preservation in advanced squamous cell carcinoma of the glottic larynx.
Furusaka T; Matsuda A; Tanaka A; Matsuda H; Ikeda M
Acta Otolaryngol; 2013 Jun; 133(6):633-40. PubMed ID: 23394224
[TBL] [Abstract][Full Text] [Related]
8. Laryngeal preservation in stage III/IV resectable laryngo-hypopharyngeal squamous cell carcinoma following concurrent chemoradiotherapy with capecitabine/cisplatin.
Ahn D; Kim JH; Sohn JH; Sin CM; Lee JE
Mol Clin Oncol; 2013 Jul; 1(4):685-691. PubMed ID: 24649229
[TBL] [Abstract][Full Text] [Related]
9. Superselective intra-arterial cisplatin infusion and concomitant radiotherapy for maxillary sinus cancer.
Homma A; Sakashita T; Yoshida D; Onimaru R; Tsuchiya K; Suzuki F; Yasuda K; Hatakeyama H; Furusawa J; Mizumachi T; Kano S; Inamura N; Taki S; Shirato H; Fukuda S
Br J Cancer; 2013 Dec; 109(12):2980-6. PubMed ID: 24196792
[TBL] [Abstract][Full Text] [Related]
10. Concurrent intra-arterial chemotherapy and radiotherapy for advanced laryngeal cancer.
Yoshizaki T; Kondo S; Wakisaka N; Murono S; Kitagawa N; Tsuji A; Nakashima M; Sanada J; Matsui O
Ann Otol Rhinol Laryngol; 2009 Mar; 118(3):172-8. PubMed ID: 19374147
[TBL] [Abstract][Full Text] [Related]
11. Radiation with concomitant superselective intra-arterial cisplatin infusion for maxillary sinus squamous cell carcinoma.
Ebara T; Ando K; Eishima J; Suzuki M; Kawakami T; Horikoshi H; Tamaki Y
Jpn J Radiol; 2019 Jun; 37(6):494-499. PubMed ID: 30915648
[TBL] [Abstract][Full Text] [Related]
12. Treatment of advanced head and neck cancer with intra-arterial cisplatin and concurrent radiation therapy: the 'RADPLAT' protocol.
Kumar P; Robbins KT
Curr Oncol Rep; 2001 Jan; 3(1):59-65. PubMed ID: 11123871
[TBL] [Abstract][Full Text] [Related]
13. Induction chemotherapy followed by cisplatin or cetuximab concomitant to radiotherapy for laryngeal/hypopharyngeal cancer: Long-term results of the TREMPLIN randomised GORTEC trial.
Janoray G; Pointreau Y; Alfonsi M; Sire C; Geoffrois L; de Raucourt D; Bardet E; Calais MH; Garaud P; Calais G
Eur J Cancer; 2020 Jul; 133():86-93. PubMed ID: 32454417
[TBL] [Abstract][Full Text] [Related]
14. T-status and an oral fluoropyrimidine, S-1, adjuvant chemotherapy are prognostic factors in reduced-RADPLAT for resectable hypopharyngeal cancer.
Wakisaka N; Hirai N; Kondo S; Aga M; Nakanishi Y; Tsuji A; Endo K; Murono S; Yoshizaki T
Acta Otolaryngol; 2016 Aug; 136(8):834-40. PubMed ID: 27007816
[TBL] [Abstract][Full Text] [Related]
15. Supradose intra-arterial cisplatin and concurrent radiation therapy for the treatment of stage IV head and neck squamous cell carcinoma is feasible and efficacious in a multi-institutional setting: results of Radiation Therapy Oncology Group Trial 9615.
Robbins KT; Kumar P; Harris J; McCulloch T; Cmelak A; Sofferman R; Levine P; Weisman R; Wilson W; Weymuller E; Fu K
J Clin Oncol; 2005 Mar; 23(7):1447-54. PubMed ID: 15735120
[TBL] [Abstract][Full Text] [Related]
16. Laryngeal preservation in advanced piriform sinus squamous cell carcinomas using superselective intra-arterial chemoradiation therapy with three agents.
Furusaka T; Matsuda A; Tanaka A; Matsuda H; Ikeda M
Acta Otolaryngol; 2013 Mar; 133(3):318-26. PubMed ID: 23153059
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up and salvage surgery in patients with T2N0M0 squamous cell carcinoma of the glottic larynx following concurrent chemoradiation therapy with cisplatin and 5-fluorouracil for laryngeal preservation.
Furusaka T; Susaki Y; Saito T; Katsura Y; Ikeda M
Acta Otolaryngol; 2013 Jan; 133(1):91-8. PubMed ID: 23106387
[TBL] [Abstract][Full Text] [Related]
18. A study of concurrent chemoradiotherapy with weekly docetaxel and cisplatin for advanced esophageal squamous cell carcinoma with T4 and/or M1 lymph node metastasis or locoregional recurrence.
Liu Q; Xia Y; Chen Y; Zhang J; Deng J; Zhao K
Radiat Oncol; 2020 Apr; 15(1):75. PubMed ID: 32268925
[TBL] [Abstract][Full Text] [Related]
19. Organ preservation and treatment toxicity with induction chemotherapy followed by radiation therapy or chemoradiation for advanced laryngeal cancer.
Guadagnolo BA; Haddad RI; Posner MR; Weeks L; Wirth LJ; Norris CM; Sullivan CA; Goguen L; Busse PM; Tishler R
Am J Clin Oncol; 2005 Aug; 28(4):371-8. PubMed ID: 16062079
[TBL] [Abstract][Full Text] [Related]
20. High-dose superselective intra-arterial cisplatin and concomitant radiation (RADPLAT) for advanced head and neck cancer.
Balm AJ; Rasch CR; Schornagel JH; Hilgers FJ; Keus RB; Schultze-Kool L; Ackerstaff AH; Busschers W; Tan IB
Head Neck; 2004 Jun; 26(6):485-93. PubMed ID: 15162349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
